ATE294586T1 - Anti-stress wirkstoffe und funktionale nährstoffe mit anti-stress effekten - Google Patents

Anti-stress wirkstoffe und funktionale nährstoffe mit anti-stress effekten

Info

Publication number
ATE294586T1
ATE294586T1 AT97934703T AT97934703T ATE294586T1 AT E294586 T1 ATE294586 T1 AT E294586T1 AT 97934703 T AT97934703 T AT 97934703T AT 97934703 T AT97934703 T AT 97934703T AT E294586 T1 ATE294586 T1 AT E294586T1
Authority
AT
Austria
Prior art keywords
stress
active ingredients
effects
functional nutrients
nutrients
Prior art date
Application number
AT97934703T
Other languages
English (en)
Inventor
Akihiro Masuyama
Masaaki Yasui
Original Assignee
Calpis Co Ltd
Groupe Danone Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calpis Co Ltd, Groupe Danone Sa filed Critical Calpis Co Ltd
Application granted granted Critical
Publication of ATE294586T1 publication Critical patent/ATE294586T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/137—Thickening substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/147—Helveticus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97934703T 1996-08-07 1997-08-06 Anti-stress wirkstoffe und funktionale nährstoffe mit anti-stress effekten ATE294586T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20850496A JP4065038B2 (ja) 1996-08-07 1996-08-07 計算作業負荷ストレス緩和剤
PCT/JP1997/002728 WO1998005343A1 (fr) 1996-08-07 1997-08-06 Medicaments anti-stress et aliments fonctionnels ayant des effets anti-stress

Publications (1)

Publication Number Publication Date
ATE294586T1 true ATE294586T1 (de) 2005-05-15

Family

ID=16557259

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97934703T ATE294586T1 (de) 1996-08-07 1997-08-06 Anti-stress wirkstoffe und funktionale nährstoffe mit anti-stress effekten

Country Status (23)

Country Link
US (1) US6596301B1 (de)
EP (1) EP0966969B1 (de)
JP (1) JP4065038B2 (de)
KR (1) KR100331141B1 (de)
CN (1) CN1112931C (de)
AR (1) AR009005A1 (de)
AT (1) ATE294586T1 (de)
AU (1) AU719204B2 (de)
BG (1) BG63074B1 (de)
BR (1) BR9711126A (de)
CA (1) CA2262652C (de)
CZ (1) CZ299912B6 (de)
DE (1) DE69733215T2 (de)
ES (1) ES2239784T3 (de)
ID (1) ID19984A (de)
MX (1) MXPA99001203A (de)
MY (1) MY124559A (de)
PT (1) PT966969E (de)
SK (1) SK285323B6 (de)
TR (1) TR199900233T2 (de)
TW (1) TW445136B (de)
WO (1) WO1998005343A1 (de)
ZA (1) ZA976989B (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4727770B2 (ja) * 1997-09-26 2011-07-20 カルピス株式会社 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤
FR2793257B1 (fr) * 1999-05-06 2001-07-27 Gervais Danone Sa Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations
SE523771C2 (sv) * 1999-05-21 2004-05-18 Probi Ab Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
GB0027761D0 (en) 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
US7718171B2 (en) * 2003-04-07 2010-05-18 Chr. Hansen A/S Reducing heart rate in mammals using milk derived fermentation products produced using Lactobacillus helveticus
EP1466529A1 (de) * 2003-04-07 2004-10-13 Chr. Hansen A/S Präparat mit herzfrequenzsenkenden Eigenschaften
US20040265279A1 (en) * 2003-05-08 2004-12-30 Timothy Dinan Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity
JP4680571B2 (ja) * 2003-12-25 2011-05-11 カルピス株式会社 経口摂取用保湿剤
US7883697B1 (en) * 2004-09-03 2011-02-08 Chr-Hansen A/S Fermented milk or vegetable proteins comprising receptor ligand and uses thereof
KR20080019059A (ko) 2005-06-24 2008-02-29 칼피스가부시키가이샤 표피세포 분화 및 각화 촉진제, 및 표피 각화 촉진용기능성 음식품
JP2007031309A (ja) * 2005-07-25 2007-02-08 Tokiwa Yakuhin Kogyo Kk 抗ストレス組成物
CN101420969B (zh) 2006-02-14 2013-03-20 卡尔皮斯株式会社 动脉硬化预防剂、血管内膜增厚抑制剂以及血管内皮功能改善剂
AU2007292786B2 (en) * 2006-09-04 2013-02-14 Megmilk Snow Brand Co., Ltd. Agent for accelerating the increase in and/or preventing the decrease in blood adiponectin level, and visceral fat accumulation inhibitor
JP2009046456A (ja) * 2007-08-23 2009-03-05 Kikkoman Corp 生殖行動の誘発用組成物
JP2008214253A (ja) 2007-03-02 2008-09-18 Snow Brand Milk Prod Co Ltd 内臓脂肪減少剤
JP5770425B2 (ja) * 2007-03-30 2015-08-26 サントリーホールディングス株式会社 副交感神経活動亢進作用を有する医薬組成物又は飲食物
US20090022853A1 (en) * 2007-07-16 2009-01-22 Conopco, Inc., D/B/A Unilever Beverage
ATE537710T1 (de) * 2008-09-05 2012-01-15 Unilever Nv Getränke, die kalium enthalten
US8273380B1 (en) 2009-05-19 2012-09-25 Jetway Inc. Fortified beverage for minimizing and/or preventing jet lag
US8928336B2 (en) 2011-06-09 2015-01-06 Ford Global Technologies, Llc Proximity switch having sensitivity control and method therefor
US8975903B2 (en) 2011-06-09 2015-03-10 Ford Global Technologies, Llc Proximity switch having learned sensitivity and method therefor
US10004286B2 (en) 2011-08-08 2018-06-26 Ford Global Technologies, Llc Glove having conductive ink and method of interacting with proximity sensor
US8994228B2 (en) 2011-11-03 2015-03-31 Ford Global Technologies, Llc Proximity switch having wrong touch feedback
US10112556B2 (en) 2011-11-03 2018-10-30 Ford Global Technologies, Llc Proximity switch having wrong touch adaptive learning and method
US9559688B2 (en) 2012-04-11 2017-01-31 Ford Global Technologies, Llc Proximity switch assembly having pliable surface and depression
US9660644B2 (en) 2012-04-11 2017-05-23 Ford Global Technologies, Llc Proximity switch assembly and activation method
US9531379B2 (en) 2012-04-11 2016-12-27 Ford Global Technologies, Llc Proximity switch assembly having groove between adjacent proximity sensors
US8933708B2 (en) 2012-04-11 2015-01-13 Ford Global Technologies, Llc Proximity switch assembly and activation method with exploration mode
US9219472B2 (en) 2012-04-11 2015-12-22 Ford Global Technologies, Llc Proximity switch assembly and activation method using rate monitoring
US9287864B2 (en) 2012-04-11 2016-03-15 Ford Global Technologies, Llc Proximity switch assembly and calibration method therefor
US9944237B2 (en) 2012-04-11 2018-04-17 Ford Global Technologies, Llc Proximity switch assembly with signal drift rejection and method
US9184745B2 (en) 2012-04-11 2015-11-10 Ford Global Technologies, Llc Proximity switch assembly and method of sensing user input based on signal rate of change
US9831870B2 (en) 2012-04-11 2017-11-28 Ford Global Technologies, Llc Proximity switch assembly and method of tuning same
US9065447B2 (en) 2012-04-11 2015-06-23 Ford Global Technologies, Llc Proximity switch assembly and method having adaptive time delay
US9197206B2 (en) 2012-04-11 2015-11-24 Ford Global Technologies, Llc Proximity switch having differential contact surface
US9568527B2 (en) 2012-04-11 2017-02-14 Ford Global Technologies, Llc Proximity switch assembly and activation method having virtual button mode
US9520875B2 (en) 2012-04-11 2016-12-13 Ford Global Technologies, Llc Pliable proximity switch assembly and activation method
US9136840B2 (en) 2012-05-17 2015-09-15 Ford Global Technologies, Llc Proximity switch assembly having dynamic tuned threshold
US8981602B2 (en) 2012-05-29 2015-03-17 Ford Global Technologies, Llc Proximity switch assembly having non-switch contact and method
US9337832B2 (en) 2012-06-06 2016-05-10 Ford Global Technologies, Llc Proximity switch and method of adjusting sensitivity therefor
US9641172B2 (en) 2012-06-27 2017-05-02 Ford Global Technologies, Llc Proximity switch assembly having varying size electrode fingers
US8922340B2 (en) 2012-09-11 2014-12-30 Ford Global Technologies, Llc Proximity switch based door latch release
US8796575B2 (en) 2012-10-31 2014-08-05 Ford Global Technologies, Llc Proximity switch assembly having ground layer
US9311204B2 (en) 2013-03-13 2016-04-12 Ford Global Technologies, Llc Proximity interface development system having replicator and method
WO2015133122A1 (ja) * 2014-03-04 2015-09-11 カルピス株式会社 鎮静用の自律神経調整剤及び日周リズム改善剤
US10038443B2 (en) 2014-10-20 2018-07-31 Ford Global Technologies, Llc Directional proximity switch assembly
US9654103B2 (en) 2015-03-18 2017-05-16 Ford Global Technologies, Llc Proximity switch assembly having haptic feedback and method
US9548733B2 (en) 2015-05-20 2017-01-17 Ford Global Technologies, Llc Proximity sensor assembly having interleaved electrode configuration
JP6285994B2 (ja) * 2016-08-09 2018-02-28 株式会社明治 シトルリン含有発酵乳およびその製造方法
KR20180019474A (ko) * 2016-08-16 2018-02-26 주식회사 엠디헬스케어 락토바실러스 플란타룸 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물
JP2018075036A (ja) * 2018-02-02 2018-05-17 株式会社明治 シトルリン含有発酵乳およびその製造方法
EP3782632A4 (de) * 2018-03-27 2021-12-15 Morinaga Milk Industry Co., Ltd. Antistress-zusammensetzung
JP2020039308A (ja) * 2018-09-12 2020-03-19 キリンホールディングス株式会社 労働パフォーマンスの向上用組成物
JPWO2022196488A1 (de) * 2021-03-15 2022-09-22

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6153216A (ja) * 1984-08-23 1986-03-17 Rikagaku Kenkyusho 高血圧症予防治療剤
JPS61153216A (ja) 1984-12-27 1986-07-11 Kawasaki Steel Corp 高炉内への粉体吹き込み方法
US4931430A (en) * 1987-12-14 1990-06-05 E. R. Squibb & Sons, Inc. Method for preventing or treating anxiety employing an ACE inhibitor
JP2855283B2 (ja) * 1990-04-23 1999-02-10 株式会社ヤクルト本社 抗潰瘍剤およびその製造法
CH683223A5 (fr) * 1991-10-25 1994-02-15 Nestle Sa Procédé de préparation d'un lait acidifié.
JP2782142B2 (ja) * 1992-07-23 1998-07-30 カルピス株式会社 アンジオテンシン変換酵素阻害剤及びその製造法
FR2703219B1 (fr) * 1993-04-01 1995-05-05 Abram Cala Le pain fait au kéfir.
KR960009004B1 (ko) * 1993-09-01 1996-07-10 안기영 셀레늄 함유 유산균 식품 및 그의 제조방법
JP2824821B2 (ja) * 1993-11-04 1998-11-18 カルピス株式会社 乳酸菌及び発酵乳製品
DE4411108A1 (de) * 1994-03-30 1995-10-05 Basf Ag Verwendung von fermentativ erhaltenen Milchprodukten zur Behandlung von Hauterkrankungen
JP2855078B2 (ja) * 1994-08-16 1999-02-10 雪印乳業株式会社 ケフィール様発酵乳とその製造方法

Also Published As

Publication number Publication date
JP4065038B2 (ja) 2008-03-19
CN1112931C (zh) 2003-07-02
MY124559A (en) 2006-06-30
CZ299912B6 (cs) 2008-12-29
ZA976989B (en) 1999-05-06
BG103228A (en) 2000-05-31
ES2239784T3 (es) 2005-10-01
AU3782897A (en) 1998-02-25
DE69733215D1 (de) 2005-06-09
EP0966969A1 (de) 1999-12-29
AR009005A1 (es) 2000-03-08
TR199900233T2 (xx) 1999-06-21
DE69733215T2 (de) 2006-02-16
KR20000029867A (ko) 2000-05-25
KR100331141B1 (ko) 2002-04-01
MXPA99001203A (es) 2004-11-22
CN1232400A (zh) 1999-10-20
CZ38699A3 (cs) 1999-07-14
ID19984A (id) 1998-09-03
EP0966969B1 (de) 2005-05-04
JPH1045610A (ja) 1998-02-17
US6596301B1 (en) 2003-07-22
BR9711126A (pt) 2000-01-11
WO1998005343A1 (fr) 1998-02-12
EP0966969A4 (de) 2000-04-26
AU719204B2 (en) 2000-05-04
TW445136B (en) 2001-07-11
SK14599A3 (en) 2000-03-13
PT966969E (pt) 2005-08-31
CA2262652C (en) 2004-02-10
CA2262652A1 (en) 1998-02-12
SK285323B6 (sk) 2006-11-03
BG63074B1 (bg) 2001-03-30

Similar Documents

Publication Publication Date Title
ATE294586T1 (de) Anti-stress wirkstoffe und funktionale nährstoffe mit anti-stress effekten
GB2297336B (en) Junction members and their uses
DE69507306T2 (de) Lehr-und unterhaltungsvorrichtung mit dynamischer gestaltung und arbeitsgang
DE69728001D1 (de) Prothese mit veränderbarer Passungs- und Spannungsverteilung
HUP0000369A3 (en) 3-thiocarbamoylpyrazole derivatives and their use as pesticides
ATE223207T1 (de) Tablette mit instant- und verzögerte freisetzung von einen oder mehrere wirkstoffe
DE69515891T8 (de) Verbundstoff und saugfähiges Kleidungsstück mit diesem Verbundstoff
DE59608321D1 (de) Kosmetikum mit kondensierten abbauprodukten pflanzlicher und tierischer herkunft
DE69620012D1 (de) Saugfähiger artikel mit verbesserten elastischen rändern und behältersystem
ZA939416B (en) Modified lipolytic enzymes and their use
ZA985514B (en) Disposasble absorbent articles with improved skin dryness performance and with improved skin aeration
GR3035382T3 (en) Active substance combinations comprising pyrethroids and insect-development inhibitors
SG47344A1 (en) Active matrix display device and timing generator
AU1283897A (en) Absorbent article with apertured backsheet and fibrous super absorbent material
ITTO950112A0 (it) Composizione e procedimemto per prevenire e trattare infiammazioni conimmunoglobina a.
BR9508264A (pt) Estrutura e artigo absorventes
ATE186541T1 (de) Quillajasaponin-zusatz und diesen enthaltende impfstoffformulierung
ZA939415B (en) Modified lipolytic enzymes and their use
GB9305120D0 (en) Neuropeptides and their use as insecticides
IL116001A0 (en) Alkoxyimino-acetimidates and their use as pesticides
GB9416402D0 (en) Application of sulpher in agriculture
ZA959904B (en) Iminooxymethyleneanilides thei preparation and their use
DE69622082T2 (de) Verbindungsmodul mit abnehmbaren Kontakten und Anwendung in Verbindungsleisten
HU9603575D0 (en) Amino-acid-derivatives and their use as pesticide
GB9010359D0 (en) Enzyme and its preparation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0966969

Country of ref document: EP